MMP9 and malignant colon neoplasm: A previous study reported that PARPs activate the metastasis-related genes integrin β-1, matrix metallopeptidase-2 (MMP-2), and MMP-9 through the nuclear factor kappa-light-chain pathway in colon cancer [46].